Follow The Filings

RH

Earnings company data as of 4:51 AM ET 10/23

History

2 periods, newest first. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q4 10 Dec EPS 0.67 — —
Rev — — —
FY2026 Q2 10 Sep EPS 0.46 — —
Rev $916.2M $922.2M Beat +0.6%

Insider trades

Open-market buys and sales by RH's executives, directors and 10% owners in the last 12 months, from their Form 4s

All RH insider trades
  • $1.8M bought by 1 insider
  • $23.1M sold by 2 insiders outside a trading plan
  • $3.4M sold by 1 insider under 10b5-1 plans
  1. Mark S Demilio Director
    Sale
    $132K 1,000 shares at $132.00 3.7% of stake
    Traded Sep 22 Filed Sep 24
  2. Mark S Demilio Director
    Sale
    $412K 2,445 shares at $168.44 8.7% of stake
    Traded Jul 10 Filed Jul 13
  3. Gary G Friedman CEO
    Sale
    $20.7M 125,000 shares at $165.35 3.7% of stake
    Traded Jul 6–8 Filed Jul 8
  4. Carlos Alberini Director
    Buy
    $1.8M 11,388 shares at $160.90 +55% to stake
    Traded Jun 29 Filed Jul 1
  5. Mark S Demilio Director
    Sale
    $777K 5,304 shares at $146.49 17% of stake
    Traded Jun 16–18 Filed Jun 18
  6. Eri Chaya See Remarks
    Planned sale
    $1.5M 11,000 shares at $137.92 100% of stake
    Traded Mar 31 Filed Apr 1
  7. Eri Chaya See Remarks
    Planned sale
    $906K 7,000 shares at $129.42 100% of stake
    Traded Mar 24 Filed Mar 25
  8. Eri Chaya See Remarks
    Planned sale
    $947K 7,000 shares at $135.34 100% of stake
    Traded Mar 17 Filed Mar 18
  9. Mark S Demilio Director
    Sale
    $936K 4,254 shares at $220.05 18% of stake
    Traded Jan 13–14 Filed Jan 15
  10. Mark S Demilio Director
    Sale
    $164K 900 shares at $182.30 3.7% of stake
    Traded Dec 30–31 Filed Jan 2

Also filed in the last 12 months, not counted as buying or selling: 8 stock grants and 6 option exercises.

SEC filings

Recent issuer filings from EDGAR, 17 shown.

Filed Form Detail Links
10-Q
8-K 2.02,9.01
SCHEDULE 13G/A —
SCHEDULE 13G/A —
8-K 7.01,9.01
SCHEDULE 13D/A —
8-K 7.01,9.01
8-K 5.07
8-K 2.02,9.01
10-Q
SCHEDULE 13G —
DEF 14A
DEFA14A
SCHEDULE 13G —
10-K
8-K 2.02,9.01
SCHEDULE 13G/A —

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.